Exact FDA event identifier

Event 89712

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: March 02, 2022
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Golden State Medical Supply Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.

D-0654-2022

Recall number: D-0654-2022
Initiated: March 02, 2022
Classification: Class II
Status: Terminated
Recalling firm: Golden State Medical Supply Inc.
Quantity: 401 bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

CGMP Deviation

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.

Code information

Lot #: GS027852, Expiry: 06/2022.

Distribution pattern

Distributed to 1 wholesaler/distributor